Bio-Techne
$72.40Change from previous close: −0.10%Absolute change: −$0.07
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $11.35B
- Enterprise value
- $11.38B
- P/E (trailing 12 months)
- 62.4
- Forward P/E
- 31.3
- PEG
- 2.11
- Price/book
- 5.36
- Price/sales
- 9.34
- EV/EBITDA
- 34.1
- EV/revenue
- 9.36
Profitability and growth
- Gross margin
- 66.2%
- Operating margin
- 27.9%
- Net margin
- 15.0%
- ROE
- 9.0%
- ROA
- 6.7%
- Revenue growth (year over year)
- 1.3%
Financial health
- Total cash
- $265.48M
- Total debt
- $289.09M
- Debt/equity
- 0.14
- Current ratio
- 4.55
- Quick ratio
- 2.95
Dividends
- Annual dividend per share
- $0.32
- Dividend yield
- 0.4%
- Payout ratio
- 27.6%
- Ex-dividend date
- August 24, 2026
Analysts and estimates
- Average price target
- $70.50
- Median price target
- $73.00
- High price target
- $73.00
- Low price target
- $50.00
- Analysts with a price target
- 10
- Consensus
- Hold
- Forward EPS
- $2.31
- EPS estimate, current year
- $2.02
Shares and trading
- Beta
- 1.28
- Average volume
- 3.34M
- Shares outstanding
- 156.82M
- Float
- 156.16M
- Institutional ownership
- 114.8%
- Insider ownership
- 0.3%
- Short interest (% of float)
- 4.8%
- Short ratio (days)
- 2.70